12399456https://www.upal.com.my/zh/feeds/jobFeedKwongwahArray ( [0] => HTTP/1.1 200 OK [1] => Date: Thu, 09 Oct 2025 13:44:16 GMT [2] => Content-Type: text/xml; charset=utf-8 [3] => Connection: close [4] => Cache-Control: no-cache, private [5] => Cache-Control: no-cache, no-store, must-revalidate [6] => Nel: {"report_to":"cf-nel","success_fraction":0.0,"max_age":604800} [7] => x-frame-options: SAMEORIGIN [8] => x-content-type-options: nosniff [9] => x-xss-protection: 1; mode=block [10] => referrer-policy: strict-origin-when-cross-origin [11] => permissions-policy: geolocation=(), microphone=(), camera=() [12] => content-security-policy: default-src * 'unsafe-inline' 'unsafe-eval' data: blob:; script-src * 'unsafe-inline' 'unsafe-eval' data: blob:; style-src * 'unsafe-inline' data:; img-src * data: blob:; font-src * data:; connect-src *; frame-src *; object-src *; media-src *; child-src *; [13] => Server: cloudflare [14] => x-robots-tag: noindex, nofollow, nosnippet, noarchive [15] => strict-transport-security: max-age=31536000; includeSubDomains; preload [16] => expires: Fri, 10 Oct 2025 13:44:16 GMT [17] => vary: Accept-Encoding [18] => Report-To: {"group":"cf-nel","max_age":604800,"endpoints":[{"url":"https://a.nel.cloudflare.com/report/v4?s=2hLVFtciI0A1TNeAZ5BmdIt%2BH00k5Or3DMokLUXN6Wttxt%2F9AnHWQGFZXX5JQbaa4tqNRRixdKCbeSxplB8smQcQFAruJBS9vE9LZKE%3D"}]} [19] => cf-cache-status: DYNAMIC [20] => Speculation-Rules: "/cdn-cgi/speculation" [21] => Server-Timing: cfCacheStatus;desc="DYNAMIC" [22] => Server-Timing: cfEdge;dur=2,cfOrigin;dur=76 [23] => Set-Cookie: UpalLiveSession=eyJpdiI6IldqRUpRcFwvZnVRQ2xucGxqREorNjd3PT0iLCJ2YWx1ZSI6IjdcL1Z1aEFOaVhQa0I4aTdsTUhKblVidlRuK1VVd1JDa05OdDFETW9UWVRuMTJhXC9ZaXBFYVJ5Y1Q0eVl4OVhBR0pKeFZSd0xJeWRNbkNJT1pNZjZLeXc9PSIsIm1hYyI6ImFhNGNmMDg4ODNiNjllNmI5YTg4ODQwNTdlNTcwYTI3MDM2NGRhYzRhMWYxZjEwYjE2NGE1NjY5YzMzMWE2NTgifQ%3D%3D; HttpOnly; Path=/; Max-Age=94608000; Expires=Sun, 08 Oct 2028 13:44:16 GMT [24] => CF-RAY: 98be4fccdfc9fc5d-KUL [25] => alt-svc: h3=":443"; ma=86400 ) 789

新冠肺炎肆虐，法国南部马赛一名权威教授，报称成功试验药物对抗新冠肺炎，初步试验显示它可以在6天内制止病毒传播。

拉乌尔是马赛医院大学地中海传染科主管，受法国政府邀请研究对抗新冠肺炎的药物。他本周发放片段，称对首批病人给予磷酸氯喹，发现迅速治愈，并大大减低病毒传播能力时间。磷酸氯喹通常用来预防及医治疟疾，商用药名为Plaquenil。

在法国东南部的24名首批感染病人，自愿入院接受这药物治疗试验。在10天内他们每天服用600微克，受到紧密看护，因为它可能与其他药物产生互相作用，在一些情况下会出现严重副作用。

拉乌尔表示，没有服用Plaquenil的病人，在6天后仍有传染能力，但那些曾服用的病人，25%在6天后已不再会传染他人。根据法国媒体上月报道，中国使用氯喹治疗新型冠状病毒初见成效，但法国医学界强调其毒性，呼吁服用时持谨慎态度。